Hypertension:血管生成抑制诱导血压升高的盐敏感性!

2017-03-21 xing.T MedSci原创

由此可见,舒尼替尼可以诱导高血压,可以被摄入高盐而加重,但不伴有皮肤淋巴管受损。

为响应盐负荷,皮肤中Na+和Cl-聚集和过量水分,刺激皮肤淋巴管生成通过激活单核吞噬细胞系统来源的血管内皮生长因子-C-血管内皮生长因子3型受体信号转导通路。该通路的抑制可以导致盐敏感性高血压舒尼替尼是一种抗血管生成、抗癌剂,可以阻断所有血管内皮生长因子3型受体并且升高血压。近日,心血管权威杂志Hypertension上发表了一篇研究文章,研究人员探讨了舒尼替尼诱导高血压的盐依赖性,并且评估了皮肤淋巴管生成障碍是否是其发生的一个潜在的机制。

研究人员将血压正常的Wistar–京都大鼠暴露于正常或高盐,并给予或不给予舒尼替尼处理。通过遥感测量发现舒尼替尼诱导血压上升15mmHg,并且这可以被高盐饮食(HSD)所加重,导致压力-钠曲线的斜率下降。并不影响体重、血浆钠离子浓度或肾功能、在高盐组大鼠Na+和Cl-的皮肤含量分别增加了31%和32%,而在HSD联合舒尼替尼组分别增加了49%和50%,而皮肤水含量分别增加了17%和24%。皮肤单核吞噬细胞系统的细胞密度在接触舒尼替尼和HSD期间都有所增加,当将HSD和舒尼替尼联合时,但没有观察到进一步的增加。HSD增加皮肤淋巴管生成,而舒尼替尼趋于减少淋巴管生成,在正常盐饮食和HSD。

由此可见,舒尼替尼可以诱导高血压,可以被摄入高盐而加重,但不伴有皮肤淋巴管受损。

原始出处:

Stephanie Lankhorst, et al. Salt Sensitivity of Angiogenesis Inhibition–Induced Blood Pressure Rise Role of Interstitial Sodium Accumulation?.Hypertension. 2017. https://doi.org/10.1161/HYPERTENSIONAHA.116.08565

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1726320, encodeId=da671e26320d8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Oct 14 01:57:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038604, encodeId=53a62038604cc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Jul 09 10:57:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718934, encodeId=26011e18934df, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Jun 30 02:57:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742081, encodeId=827c1e4208118, content=<a href='/topic/show?id=856ce226469' target=_blank style='color:#2F92EE;'>#盐敏感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72264, encryptionId=856ce226469, topicName=盐敏感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e22335030135, createdName=wjcjjian, createdTime=Tue Jul 04 19:57:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388341, encodeId=c4e913883412d, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501133, encodeId=ae81150113301, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-10-14 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1726320, encodeId=da671e26320d8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Oct 14 01:57:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038604, encodeId=53a62038604cc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Jul 09 10:57:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718934, encodeId=26011e18934df, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Jun 30 02:57:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742081, encodeId=827c1e4208118, content=<a href='/topic/show?id=856ce226469' target=_blank style='color:#2F92EE;'>#盐敏感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72264, encryptionId=856ce226469, topicName=盐敏感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e22335030135, createdName=wjcjjian, createdTime=Tue Jul 04 19:57:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388341, encodeId=c4e913883412d, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501133, encodeId=ae81150113301, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1726320, encodeId=da671e26320d8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Oct 14 01:57:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038604, encodeId=53a62038604cc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Jul 09 10:57:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718934, encodeId=26011e18934df, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Jun 30 02:57:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742081, encodeId=827c1e4208118, content=<a href='/topic/show?id=856ce226469' target=_blank style='color:#2F92EE;'>#盐敏感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72264, encryptionId=856ce226469, topicName=盐敏感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e22335030135, createdName=wjcjjian, createdTime=Tue Jul 04 19:57:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388341, encodeId=c4e913883412d, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501133, encodeId=ae81150113301, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1726320, encodeId=da671e26320d8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Oct 14 01:57:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038604, encodeId=53a62038604cc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Jul 09 10:57:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718934, encodeId=26011e18934df, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Jun 30 02:57:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742081, encodeId=827c1e4208118, content=<a href='/topic/show?id=856ce226469' target=_blank style='color:#2F92EE;'>#盐敏感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72264, encryptionId=856ce226469, topicName=盐敏感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e22335030135, createdName=wjcjjian, createdTime=Tue Jul 04 19:57:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388341, encodeId=c4e913883412d, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501133, encodeId=ae81150113301, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1726320, encodeId=da671e26320d8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Oct 14 01:57:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038604, encodeId=53a62038604cc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Jul 09 10:57:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718934, encodeId=26011e18934df, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Jun 30 02:57:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742081, encodeId=827c1e4208118, content=<a href='/topic/show?id=856ce226469' target=_blank style='color:#2F92EE;'>#盐敏感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72264, encryptionId=856ce226469, topicName=盐敏感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e22335030135, createdName=wjcjjian, createdTime=Tue Jul 04 19:57:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388341, encodeId=c4e913883412d, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501133, encodeId=ae81150113301, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1726320, encodeId=da671e26320d8, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Oct 14 01:57:00 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038604, encodeId=53a62038604cc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Sun Jul 09 10:57:00 CST 2017, time=2017-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718934, encodeId=26011e18934df, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Jun 30 02:57:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1742081, encodeId=827c1e4208118, content=<a href='/topic/show?id=856ce226469' target=_blank style='color:#2F92EE;'>#盐敏感#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72264, encryptionId=856ce226469, topicName=盐敏感)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e22335030135, createdName=wjcjjian, createdTime=Tue Jul 04 19:57:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1388341, encodeId=c4e913883412d, content=<a href='/topic/show?id=7ef25e5346b' target=_blank style='color:#2F92EE;'>#敏感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57534, encryptionId=7ef25e5346b, topicName=敏感性)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJnkE6UvGFfMS41qV0RicWvVTTeLMicqibeZH5GqO4YhNicyl1Y9jFhylIUBn9ntPYy9jhk5hrfic5cRYw/132, createdBy=5f822500020, createdName=ms5236388012055669, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501133, encodeId=ae81150113301, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Thu Mar 23 05:57:00 CST 2017, time=2017-03-23, status=1, ipAttribution=)]

相关资讯

Cancer Res:饮食和运动可降低肿瘤发展相关生物标志物

根据一项随机试验的结果,肥胖和超重的绝经后妇女通过饮食和运动减肥,其血管生成的血清标志物降低了。这些生物标志物包括血管内皮生长因子(VEGF)、色素上皮衍生因子(PEDF)和纤溶酶原激活物抑制剂-1(PAI-1)。弗莱德哈钦森西雅图癌症护理联盟癌症研究中心公共健康科学部的Catherine Duggan博士和他的同事们对439名绝经后女性(84.9%为非西班牙裔白人;平均年龄57.9岁;平均BMI

JNCI:科学家发现新淋巴结转移灶不会形成新生血管

有研究表明使用抗血管生成药物阻断新血管生长对于提高一些癌症的治疗效果具有一定作用,但临床数据表明这些药物在抑制新转移灶形成方面发挥的作用并不尽如人意。近日,来自美国马萨诸塞总医院癌症中心的研究人员发现了导致这一结果发生的一个可能原因,相关研究结果发表在国际学术期刊Journal of the National Cancer Institute上。   在这项研究中,研究人员发现癌细胞

Clin Cancer Res:索拉非尼抗肝癌血管生成机制

在肝癌中,肝细胞是过表达缺氧诱导因子(HIF)-1α的,HIF-1α导致血管生成和肝癌患者预后较差。索拉非尼是一种多激酶抑制剂,已经在临床试验中证明能显著改善晚期肝癌患者生存率。然而,索拉非尼的抗血管生成机制尚未完全阐明。一项最新发表在Clinical Cancer Research杂志上的研究旨在探讨索拉非尼对肝癌细胞和异种移植肝癌细胞HIF-1α表达和活化的影响。 该研究采用Western印

Cancer Res:饮食和锻炼能降低绝经后女性患癌风险

这项发表在Cancer Research杂志上的新近研究指出,通过饮食和锻炼达到减肥目的的肥胖和超重女性血液内参与血管生成相关蛋白质水平降低。 血管生成是指受损血管修复和新血管生成,如果没有氧气和营养物质的供应,机体正常细胞和癌细胞都无法生存。当这些细胞发出相应信号即血管生成因子以促进新血管的生长、癌细胞发展为肿瘤。如果没有血液供应,肿瘤的直径也就几毫米左右。然而,一旦有一些肿瘤细胞分泌相关物质刺

Blood:阎锡蕴等发现肿瘤血管生成新机制

6月20日,Blood杂志在线发表了中国科学院生物物理研究所阎锡蕴课题组在肿瘤血管生成方面的最新研究成果。这是该课题组继发现CD146是肿瘤血管新靶标之后的又一重大突破。 此项研究揭示了肿瘤血管内皮标志分子CD146作为细胞表面受体促进血管生成的最新分子机制,是CD146作为肿瘤血管生成标志分子的最直接证据。这一发现最重要的意义是其提供了一种更加有效的治疗肿瘤的新策略,即靶向CD146作为VEG

SSAT:血管生成与小儿克罗恩病相关

图1 图2   5月18日,在即将召开的2013美国消化疾病周上,来自美国俄亥俄州辛辛那提儿童医院医疗中心的研究者珍妮弗将发表题为《小儿克罗恩病血管内皮生长因子表达,血管生成和炎症关系》的演讲。早发型克罗恩病(CD)占克罗恩病的25%,但是有别于成人型CD,其疾病活动指数更严重,免疫抑制剂要求增加,肠道参与更广泛。慢性炎性疾病和血管生成之间的致病关系,促使研究其在炎性肠病中的作用。研究者推测血